Our in vitro studies clearly showed that TGM4 decreases the number of viable pancreatic tumor cells (Mia-PaCa-2 and PANC-1) in a time- and concentration-dependent manner (Figure 2). The gene discussed is TGM4; the disease is pancreatic neoplasm.